CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 105 filers reported holding CYTEK BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,309,222 | -31.3% | 1,142,975 | +6.4% | 0.00% | -50.0% |
| Q2 2023 | $9,177,494 | +3.2% | 1,074,648 | +11.0% | 0.00% | 0.0% |
| Q1 2023 | $8,894,908 | -7.3% | 967,890 | +3.0% | 0.00% | 0.0% |
| Q4 2022 | $9,596,858 | -29.3% | 939,947 | +2.0% | 0.00% | -33.3% |
| Q3 2022 | $13,567,000 | +52.6% | 921,669 | +11.2% | 0.00% | +50.0% |
| Q2 2022 | $8,890,000 | +16.6% | 828,616 | +17.1% | 0.00% | +100.0% |
| Q1 2022 | $7,627,000 | +192.4% | 707,463 | +342.7% | 0.00% | – |
| Q4 2021 | $2,608,000 | -15.3% | 159,805 | +11.1% | 0.00% | -100.0% |
| Q3 2021 | $3,080,000 | – | 143,859 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,100,000 | $22,533,000 | 12.24% |
| Miura Global Management | 1,649,400 | $17,698,000 | 12.14% |
| RA Capital Management | 13,381,054 | $143,578,000 | 3.83% |
| HHLR ADVISORS, LTD. | 8,757,030 | $93,963,000 | 2.01% |
| PURA VIDA INVESTMENTS, LLC | 477,164 | $5,120,000 | 0.30% |
| RTW INVESTMENTS, LP | 916,838 | $9,838,000 | 0.25% |
| Glenview Capital Management | 500,000 | $5,365,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 73,743 | $791,000 | 0.12% |
| Parkwood LLC | 42,292 | $454,000 | 0.08% |
| Point72 Asset Management, L.P. | 1,536,079 | $16,482,000 | 0.07% |